World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
44
Citations
21513
World Ranking
2885
National Ranking
1373

J. Fraser Wright publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where J. Fraser Wright sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 85 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

J. Fraser Wright D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where J. Fraser Wright sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 44 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

J. Fraser Wright is affiliated with Stanford University in the United States. Their research spans multiple areas within biochemistry, genetics, molecular biology, and medicine, focusing extensively on molecular biology and genetics as core subfields.

The scientist's work covers a range of topics, notably:

  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • CRISPR and Genetic Engineering
  • Viral gastroenteritis research and epidemiology
  • RNA Interference and Gene Delivery
  • Viral Infections and Immunology Research

J. Fraser Wright has contributed significantly to several publication venues. Frequent venues include:

  • Molecular Therapy - Methods & Clinical Development
  • Molecular Therapy
  • Cytotherapy
  • Science Translational Medicine
  • Frontiers in Immunology

Their recent papers illustrate a focus on gene therapy and viral vector research. Examples include:

  • "Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease," 2021, Science Translational Medicine
  • "Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes," 2021, Frontiers in Immunology
  • "Quality Control Testing, Characterization and Critical Quality Attributes of Adeno-Associated Virus Vectors Used for Human Gene Therapy," 2020, Biotechnology Journal
  • "Codon Modification and PAMPs in Clinical AAV Vectors: The Tortoise or the Hare?" 2020, Molecular Therapy
  • "Quantification of CpG Motifs in rAAV Genomes: Avoiding the Toll," 2020, Molecular Therapy

Co-authorship connections are evident with several researchers, including:

  • Rosa Bacchetta
  • Bruce Alberts
  • Kyriacos Mitrophanous
  • Matthew H. Porteus
  • Yohei Sato

Overall, J. Fraser Wright's body of work contributes to understanding and developing viral vector technology and gene therapy methods within molecular biology and genetics frameworks, furthering areas such as immune responses to viral vectors and gene correction techniques.

Best Publications

  • Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

    Stephan A. Grupp;Michael Kalos;David Barrett;Richard Aplenc

  • Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

    Albert M. Maguire;Francesca Simonelli;Eric A. Pierce;Edward N. Pugh

  • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Manno Cs;Pierce Gf;Arruda Vr;Glader B

  • Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

    Stephen Russell;Jean Bennett;Jennifer A. Wellman;Daniel C. Chung

  • Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

    Albert M. Maguire;Albert M. Maguire;Katherine A. High;Katherine A. High;Alberto Auricchio;J. Fraser Wright;J. Fraser Wright

  • Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.

    Lindsey A. George;Spencer K. Sullivan;Adam Giermasz;John E.J. Rasko;John E.J. Rasko

  • Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

    Francesca Simonelli;Albert M Maguire;Albert M Maguire;Francesco Testa;Eric A Pierce

  • Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

    Jean Bennett;Jean Bennett;Jennifer Wellman;Kathleen A Marshall;Sarah McCague

  • AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

    Jean Bennett;Jean Bennett;Manzar Ashtari;Jennifer Wellman;Kathleen A. Marshall

  • Three-Year Follow-up after Unilateral Subretinal Delivery of Adeno-Associated Virus in Patients with Leber Congenital Amaurosis Type 2

    Francesco Testa;Albert M. Maguire;Albert M. Maguire;Settimio Rossi;Eric A. Pierce

  • High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

    E Ayuso;F Mingozzi;J Montane;X Leon

  • Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.

    Albert M. Maguire;Albert M. Maguire;Stephen Russell;Jennifer A. Wellman;Daniel C. Chung

  • Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver

    Federico Mingozzi;Nicole C. Hasbrouck;Etiena Basner-Tschakarjan;Shyrie A. Edmonson;Shyrie A. Edmonson

  • Assessing the potential for AAV vector genotoxicity in a murine model

    Hojun Li;Nirav Malani;Shari R. Hamilton;Alexander Schlachterman

  • Progress and challenges in viral vector manufacturing.

    Johannes C.M. van der Loo;J. Fraser Wright

  • Quantification of adeno-associated virus particles and empty capsids by optical density measurement.

    J.ürg M Sommer;Peter H Smith;Sumathy Parthasarathy;Jesse Isaacs

  • Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.

    Catherine Cukras;Henry E. Wiley;Brett G. Jeffrey;H. Nida Sen

  • Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation

    J. Fraser Wright;Tannie Le;Joseph Prado;Jennifer Bahr-Davidson

  • Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography.

    Guang Qu;Jennifer Bahr-Davidson;Joseph Prado;Alex Tai

  • Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.

    Federico Mingozzi;Yifeng Chen;Yifeng Chen;Samuel L Murphy;Shyrie C Edmonson;Shyrie C Edmonson

Frequent Co-Authors

Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Federico Mingozzi
Federico Mingozzi Children's Hospital of Philadelphia
Albert M. Maguire
Albert M. Maguire University of Pennsylvania
Valder R. Arruda
Valder R. Arruda University of Pennsylvania
Jean Bennett
Jean Bennett University of Pennsylvania
Alberto Auricchio
Alberto Auricchio Telethon Institute Of Genetics And Medicine
Eric A. Pierce
Eric A. Pierce Massachusetts Eye and Ear Infirmary
Daniel C. Chung
Daniel C. Chung Harvard University
Edwin M. Stone
Edwin M. Stone University of Iowa
Sandro Banfi
Sandro Banfi University of Campania "Luigi Vanvitelli"

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology opens doors to various online degree options and unique career pathways. For students already in the healthcare field, online bsn to msn programs offer a fast track for advancing from nursing to higher-level clinical or research roles—an ideal choice for those interested in medical aspects of molecular biology.

Flexibility and accreditation are crucial when choosing an institution. Many learners prefer not for profit online colleges for their reputable faculty, student support, and reliable degree recognition.

Military members and veterans can pursue molecular biology or related fields with institutions known as online colleges for military. These schools are tailored to fit the unique needs and schedules of military learners, often providing generous credit transfer and tuition assistance.

Finally, for those seeking interdisciplinary options, bioscience knowledge is valuable in public health and outreach careers. Earning one of the top social work online master's programs can position graduates to apply molecular biology understanding in healthcare, policy, or community work settings.

Best Scientists Citing J. Fraser Wright

Trending Scientists

Recently Published Articles